https://www.selleckchem.com/Proteasome.html
The choice of appropriate biologic therapy for severe asthma remains challenging. The importance of finding biomarkers that can predict response continuous an open issue that needs to be further explored. This review describes the clinical effects of targeting the IL-5 pathway in severe asthma in adult and paediatric patients, focusing on predictors of response and non-response. The aim of this study is to identify the changes in patient age and stone sizes with technological advancement over time. This study was conducted retrospectively wit